Coronavirus Drug Discovery

Chukwuebuka Egbuna (PhD) is a chartered chemist and academic researcher. He is a member of the Institute of Chartered Chemists of Nigeria (ICCON), the Nigerian Society of Biochemistry and Molecular Biology (NSBMB), and the Royal Society of Chemistry (RSC) (United Kingdom). Dr. Egbuna is the founder and editor of the Elsevier book series on Drug Discovery Update. The series includes books, monographs, and edited collections from all areas of drug discovery including emerging therapeutic claims for the treatment of diseases. He has published research articles in many international journals of repute and is ranked among the top 500 Nigerian scientists in SciVal/SCOPUS. He has edited more than 25 books with Elsevier, Springer, Wiley, and Taylor & Francis. His most recent book is the three volume Coronavirus Drug Discovery, published by Elsevier. Dr. Egbuna is the founder and the publishing director of IPS Intelligentsia Publishing Services.

• PART I: ANTIVIRAL AGENTS FROM NATURAL PRODUCTS1. COVID-19 management and phytomedicine interventions: Potentials and safety considerations2. Plants with potent antiviral properties3. Antiviral effects of medicinal plants and their active phytochemical constituents against respiratory diseases and associated biological functions4. Herbs and drugs in clinical trials for coronavirus treatments5. Herbal-Based Resources against Exanthematous Viral Infections and Other Viral Diseases6. Dietary polyphenols as therapeutic agents to combat COVID-197. Bioactive compounds and herbal preparations implicated in for the treatment of SARS-CoV-28. Roles of Antioxidants in the Prevention and Management of Coronavirus Disease 20199. Food sources of natural antioxidants for body defence against SARS-CoV-210. Nutritional Management against Severe Acute Respiratory Syndrome Coronavirus-2 Infection